K. Buser
Impact in
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
- Oncology top 10%
- Cancer Treatment and Pharmacology
Papers in
- Co-authors
- Elizabeth A. Eisenhauer (1 shared paper)Nicoletta Colombo (1 shared paper)Kenneth D. Swenerton (1 shared paper)W.W. ten Bokkel Huinink (1 shared paper)M E van der Burg (1 shared paper)Ian G. Kerr (1 shared paper)Luca Gianni (1 shared paper)Jan B. Vermorken (1 shared paper)
- Journals
- Annals of Oncology (5 papers)Gynecologic Oncology (1 paper)International Journal of Oncology (1 paper)European Journal of Cancer (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- SwitzerlandItalyNetherlands
In The Last Decade
K. Buser
18 papers receiving 865 citations
K. Buser's Hit Papers
Peers
Comparison fields: 5 of 73
- Reproductive Medicine 249
- Oncology 312
- Obstetrics and Gynecology 76
- Surgery 253
- Dermatology 47
Countries citing papers authored by K. Buser
This map shows the geographic impact of K. Buser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Buser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Buser more than expected).
Fields of papers citing papers by K. Buser
This network shows the impact of papers produced by K. Buser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Buser. The network helps show where K. Buser may publish in the future.
Co-authors
The 25 scholars most cited alongside K. Buser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion. Hit paper breakdown → | 1994 | 537 |
| 2 | 1992 | 82 | |
| 3 | 2002 | 44 | |
| 4 | 1988 | 43 | |
| 5 | 1994 | 37 | |
| 6 | 1997 | 36 | |
| 7 | 1998 | 33 | |
| 8 | The symptomatic control of cytostatic drug-induced emesis. A recent history and review. | 1990 | 25 |
| 9 | 1993 | 23 | |
| 10 | 1997 | 20 | |
| 11 | 1995 | 15 | |
| 12 | 1996 | 12 | |
| 13 | 2002 | 8 | |
| 14 | 1990 | 4 | |
| 15 | 2017 | 4 | |
| 16 | [BRL 43694A--a 5-hydroxytryptamine receptor blocker as an antiemetic in cytostatic therapy]. | 1989 | 2 |
| 17 | [Ovarian carcinoma: current therapeutic aspects. A review]. | 1990 | 1 |
| 18 | [Preventive and therapeutic measures in cytostatic-associated toxicity]. | 1990 | 1 |
About K. Buser
K. Buser is a scholar working on Oncology, Surgery, Reproductive Medicine, Pathology and Forensic Medicine and Molecular Biology, having authored 18 papers that have together received 927 indexed citations. Recurring topics across this work include Nausea and vomiting management (5 papers), Ovarian cancer diagnosis and treatment (4 papers), Cancer Treatment and Pharmacology (3 papers), Chemotherapy-induced organ toxicity mitigation (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Epigenetics and DNA Methylation (1 paper) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Reproductive Medicine (249 citations), Oncology (312 citations), Obstetrics and Gynecology (76 citations), Surgery (253 citations) and Dermatology (47 citations). K. Buser has collaborated with scholars based in Switzerland, Italy and Netherlands. Frequent co-authors include Elizabeth A. Eisenhauer, Nicoletta Colombo, Kenneth D. Swenerton, W.W. ten Bokkel Huinink, M E van der Burg, Ian G. Kerr, Luca Gianni, Jan B. Vermorken, M. Bacchi and Franziska Joncourt. Their work appears in journals such as Annals of Oncology, Gynecologic Oncology, International Journal of Oncology, European Journal of Cancer and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.